Publicaciones en colaboración con investigadores/as de Erasmus University Medical Center (6)

2024

  1. Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 3, pp. 374-387

2022

  1. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study

    European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316

2019

  1. Impact of post-procedural minimal stent area on 2-year clinical outcomes in the SYNTAX II trial

    Catheterization and Cardiovascular Interventions, Vol. 93, Núm. 4, pp. E225-E234

  2. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

    The Lancet, Vol. 394, Núm. 10206, pp. 1325-1334

2017

  1. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

    European Heart Journal, Vol. 38, Núm. 42, pp. 3124-3134

2008

  1. Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: A 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-Delft)

    EuroIntervention, Vol. 4, Núm. 1, pp. 77-83